JMO but releasing 2021 AR where operational profits were more than 3X any other year in Lynas's history, an a amazing turnaround from 40M loss in 2020. I think that had a lot more to do with it than the SP. .
If they were realy watching the company they would have upgraded when Q4 report came out. So I think it is just a computer making the call based on current SP and resent results. No human looking and thinking. Most computers algorithms only look at a few things and earnings is number one. These programs created in US do not know what to do with a Q report like Lynas's. That is a knock on computer algorithms not Lynas.
Morning star rates thousands of companies around the world. In the US and many other countries the Q reports have details similar to Lynas SAR. It would be imposable to have enough people to study all of them. I have no problems with company's using computers to do this. As an investor it is important for me to understand how the report may be generated and problems that may arise because of that. JMO but 90% of reports are not worth the time to read them. Most of the good ones you have to pay to get them.
- Forums
- ASX - By Stock
- LYC
- All time high
All time high, page-106
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
|
|||||
Last
$6.35 |
Change
-0.050(0.78%) |
Mkt cap ! $5.935B |
Open | High | Low | Value | Volume |
$6.46 | $6.47 | $6.34 | $19.83M | 3.109M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11865 | $6.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.36 | 3637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 6.350 |
4 | 5536 | 6.340 |
4 | 13908 | 6.330 |
6 | 42312 | 6.320 |
6 | 24381 | 6.310 |
Price($) | Vol. | No. |
---|---|---|
6.370 | 3462 | 2 |
6.380 | 18088 | 2 |
6.390 | 11392 | 2 |
6.400 | 16874 | 4 |
6.420 | 785 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online